Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Withdraws Pre-Term Birth Drug

Roughly 1 in 10 infants born in the U.S. are preterm, placing both the baby and mother at higher risk of death or disability.

221019 Makena Mn 1000 D9738f Df7de5

According to a recent CNN article, the FDA has withdrawn its approval of Makena, a drug approved over a decade ago to reduce the risk of preterm birth, which had been the only medication approved for the condition. The FDA says the drug isn’t effective, and its benefits don’t outweigh the risks. The drug disproportionately affects Black women, for whom the rate of preterm birth is about 50% higher than for White or Hispanic women. Preterm birth has also been a growing problem in the US, with the rate rising from 10.1% in 2020 to 10.5% in 2021.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences